Search

Your search keyword '"Marchesini, G."' showing total 80 results

Search Constraints

Start Over You searched for: Author "Marchesini, G." Remove constraint Author: "Marchesini, G." Database Academic Search Index Remove constraint Database: Academic Search Index
80 results on '"Marchesini, G."'

Search Results

1. Management of dairy heifers: Can operant conditioning be an effective and feasible tool to decrease stress and ease animals' close contact and handling?

2. A Survey of Dog Owners' Attitudes toward Treats.

3. Are severe hypoglycemic episodes in diabetes correctly identified by administrative data? Evidence of underreporting from the HYPOTHESIS study.

4. Multi-jet event shapes in QCD hard processes.

5. Effect of feeding fine maize particles on the reticular p H, milk yield and composition of dairy cows.

6. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.

7. Dynamic high pressure--induced gelation in milk protein model systems.

8. Nanoscale Affinity Chip Interface for Coupling Inhibition SPR Immunosensor Screening with Nano-LC TOF MS.

9. SUSY Yang–Mills: Three loops made simple(r)

10. Revisiting parton evolution and the large-x limit

11. Hadron collisions and the fifth form factor

12. Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study.

13. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes.

14. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes.

15. BFKL dynamics in jet evolution

16. Citations and Clinicians' Notes: Liver.

17. Effects of cognitive-behavioural therapy on health-related quality of life in obese subjects with and without binge eating disorder.

18. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

19. Effects of hyperglycaemia and hyperinsulinaemia on plasma amino acid levels in obese subjects with normal glucose tolerance.

20. Azimuthal correlation in DIS

21. Review article: the treatment of fatty liver disease associated with the metabolic syndrome.

28. High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C.

30. Night eating syndrome in class II–III obesity: metabolic and psychopathological features.

31. Presence of biogenic amines in a traditional salted Italian cheese.

32. Observational approach to subjects with mild-to-moderate head injury and initial non-neurosurgical lesions.

33. Early predictors of unfavourable outcome in subjects with moderate head injury in the emergency department.

34. Twist 3 of the sector of SYM and reciprocity respecting evolution

35. Prospective validation of a proposal for diagnosis and management of patients attending the emergency department for mild head injury.

36. WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance.

37. Association of nonalcoholic fatty liver disease with insulin resistance.

38. Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease.

39. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.

40. Volatile compounds and microbial development in sonicated cloudy apple juices: preliminary results.

41. Personality, attrition and weight loss in treatment seeking women with obesity.

42. Liver in the analysis of body composition by dual-energy X-ray absorptiometry.

43. Stage of change and motivation to healthy diet and habitual physical activity in type 2 diabetes.

44. The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database.

45. A controlled, class-based multicomponent intervention to promote healthy lifestyle and to reduce the burden of childhood obesity.

46. Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance.

49. Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database.

50. TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1.

Catalog

Books, media, physical & digital resources